Agilent Technologies Current Ratio 2010-2025 | A

Current and historical current ratio for Agilent Technologies (A) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Agilent Technologies current ratio for the three months ending January 31, 2025 was 2.20.
Agilent Technologies Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-01-31 $4.11B $1.87B 2.20
2024-10-31 $3.96B $1.90B 2.09
2024-07-31 $4.26B $2.39B 1.78
2024-04-30 $4.20B $1.96B 2.15
2024-01-31 $4.34B $1.62B 2.68
2023-10-31 $4.19B $1.60B 2.61
2023-07-31 $4.03B $1.76B 2.29
2023-04-30 $3.95B $1.67B 2.37
2023-01-31 $4.08B $1.94B 2.11
2022-10-31 $3.78B $1.86B 2.03
2022-07-31 $3.69B $1.90B 1.94
2022-04-30 $3.64B $1.81B 2.01
2022-01-31 $3.47B $1.58B 2.19
2021-10-31 $3.80B $1.71B 2.22
2021-07-31 $3.63B $1.72B 2.11
2021-04-30 $3.51B $1.76B 2.00
2021-01-31 $3.48B $1.69B 2.07
2020-10-31 $3.42B $1.47B 2.33
2020-07-31 $3.25B $1.31B 2.47
2020-04-30 $3.17B $1.95B 1.63
2020-01-31 $3.10B $1.89B 1.64
2019-10-31 $3.19B $2.08B 1.53
2019-07-31 $3.46B $1.62B 2.13
2019-04-30 $3.81B $1.12B 3.41
2019-01-31 $3.71B $1.10B 3.39
2018-10-31 $3.85B $1.17B 3.29
2018-07-31 $3.67B $1.01B 3.62
2018-04-30 $4.53B $1.37B 3.32
2018-01-31 $4.40B $1.36B 3.23
2017-10-31 $4.17B $1.26B 3.30
2017-07-31 $4.00B $1.24B 3.22
2017-04-30 $3.80B $1.19B 3.20
2017-01-31 $3.64B $1.09B 3.34
2016-10-31 $3.64B $0.95B 3.85
2016-07-31 $3.53B $1.15B 3.07
2016-04-30 $3.49B $1.13B 3.08
2016-01-31 $3.40B $0.95B 3.59
2015-10-31 $3.69B $0.98B 3.78
2015-07-31 $3.48B $0.85B 4.08
2015-04-30 $3.62B $0.93B 3.89
2015-01-31 $3.65B $0.93B 3.94
2014-10-31 $5.51B $1.69B 3.26
2014-07-31 $4.83B $1.58B 3.06
2014-04-30 $5.38B $1.72B 3.13
2014-01-31 $5.07B $1.55B 3.28
2013-10-31 $4.98B $1.60B 3.11
2013-07-31 $4.58B $1.55B 2.96
2013-04-30 $4.82B $1.91B 2.53
2013-01-31 $4.71B $1.85B 2.55
2012-10-31 $4.63B $1.89B 2.45
2012-07-31 $4.21B $2.09B 2.02
2012-04-30 $6.01B $1.84B 3.28
2012-01-31 $5.72B $1.71B 3.35
2011-10-31 $5.57B $1.84B 3.03
2011-07-31 $5.22B $1.51B 3.47
2011-04-30 $5.10B $1.59B 3.20
2011-01-31 $4.60B $1.41B 3.27
2010-10-31 $6.17B $3.08B 2.00
2010-07-31 $5.74B $2.92B 1.97
2010-04-30 $5.71B $2.71B 2.11
2010-01-31 $5.52B $2.55B 2.17
2009-10-31 $3.96B $1.12B 3.53
2009-07-31 $2.90B $0.99B 2.92
2009-04-30 $2.88B $1.10B 2.62
2009-01-31 $3.01B $1.13B 2.66
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $31.721B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.294B 27.81
Boston Scientific (BSX) United States $157.073B 39.32
Stryker (SYK) United States $146.485B 30.63
EssilorLuxottica (ESLOY) France $131.510B 0.00
Medtronic (MDT) Ireland $104.117B 14.76
Haleon (HLN) United Kingdom $50.587B 28.80
Lonza Group Ag (LZAGY) Switzerland $49.544B 0.00
ResMed (RMD) United States $36.103B 27.12
GE HealthCare Technologies (GEHC) United States $32.514B 15.44
Terumo (TRUMY) Japan $28.131B 36.54
Insulet (PODD) United States $22.987B 90.23
Koninklijke Philips (PHG) Netherlands $21.694B 15.60
Zimmer Biomet Holdings (ZBH) United States $18.639B 11.97
Baxter (BAX) United States $15.842B 11.83
Smith & Nephew SNATS (SNN) United Kingdom $12.666B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.269B 21.81
Lantheus Holdings (LNTH) United States $5.242B 13.22
Prestige Consumer Healthcare (PBH) United States $4.244B 18.96
Perrigo (PRGO) Ireland $3.757B 9.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.266B 14.88
ICU Medical (ICUI) United States $3.210B 23.67
Envista Holdings (NVST) United States $3.051B 25.35
GN Store Nord (GNNDY) Denmark $2.163B 17.92
QuidelOrtho (QDEL) United States $2.114B 14.54
LeMaitre Vascular (LMAT) United States $1.868B 41.76
AtriCure (ATRC) United States $1.683B 0.00
Neogen (NEOG) United States $1.335B 17.08
Acuren (TIC) United States $1.317B 0.00
AdaptHealth (AHCO) United States $1.256B 12.75
Kestra Medical Technologies (KMTS) United States $1.156B 0.00
Green Thumb Industries (GTBIF) United States $1.120B 25.19
BioLife Solutions (BLFS) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.919B 9.26
Evolus (EOLS) United States $0.633B 0.00
CeriBell (CBLL) United States $0.625B 0.00
Curaleaf Holdings (CURLF) Canada $0.590B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.568B 0.00
Valneva SE (VALN) France $0.534B 0.00
Owens & Minor (OMI) United States $0.509B 4.22
Capricor Therapeutics (CAPR) United States $0.479B 0.00
Tilray Brands (TLRY) Canada $0.446B 0.00
Surmodics (SRDX) United States $0.412B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.339B 0.00
Cresco Labs (CRLBF) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.86
Canopy Growth (CGC) Canada $0.313B 0.00
Aurora Cannabis (ACB) Canada $0.307B 54.70
Sanara MedTech (SMTI) United States $0.274B 0.00
Viemed Healthcare (VMD) United States $0.261B 22.00
ZimVie (ZIMV) United States $0.245B 11.11
Cerus (CERS) United States $0.241B 0.00
Sanuwave Health (SNWV) United States $0.239B 0.00
Verano Holdings (VRNOF) United States $0.237B 0.00
Biote (BTMD) United States $0.223B 6.28
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
OraSure Technologies (OSUR) United States $0.207B 0.00
Brainsway (BWAY) Israel $0.201B 53.25
Quanterix (QTRX) United States $0.197B 0.00
Omeros (OMER) United States $0.186B 0.00
High Tide (HITI) Canada $0.185B 0.00
Organigram Global (OGI) Canada $0.179B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.46
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.136B 16.69
Jin Medical (ZJYL) China $0.124B 0.00
TerrAscend (TSNDF) Canada $0.114B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Agape ATP (ATPC) $0.092B 0.00
Fonar (FONR) United States $0.089B 11.42
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Zynex (ZYXI) United States $0.078B 0.00
Quipt Home Medical (QIPT) United States $0.076B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.071B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.056B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Modular Medical (MODD) United States $0.047B 0.00
United-Guardian (UG) United States $0.039B 13.47
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.86
Safety Shot (SHOT) United States $0.029B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00